Journal of Food Science and Technology

, Volume 56, Issue 12, pp 5435–5443 | Cite as

Comparative anticancer activity analysis of saffron extracts and a principle component, crocetin for prevention and treatment of human malignancies

  • Sevgi GeziciEmail author
Original Article


Saffron, obtained from dry stigmas of the flowers of Crocus sativus L. (fam. Iridaceae), is an ancient spice and a natural food colorant that has been used to treat various diseases in the long human history. Crocetin is of the main secondary metabolites of saffron and its curative properties for many ailments have been revealed in the previous scientific reports. The aim of this study was to evaluate the anticancer potentials of saffron extracts and its pure crocetin compounds against human cancer cells. The cytotoxic and antiproliferative activities along with lactate dehydrogenase activities of extracts and crocetin, a carotenoid derived from saffron, were assessed using A549, MCF-7 and HeLa human cancer cells, and compared to the non-malignant HUVECs. Additionally, apoptotic activity in the cells treated and untreated with the extracts and pure crocetin were determined in terms of DNA fragmentation. The results showed the extracts and crocetin from saffron induced cytotoxicity, enhanced cancer cell death as well as inhibited cancer cell growth in a concentration and time dependent manner. In addition, the results revealed that the tested compounds at different concentration had no cytotoxic effects on the non-malignant cells, whereas, it could significantly decrease the cell viability and proliferation in the malignant cells. As compared to anticancer potentials of the analyzed extracts and its pure crocetin compounds, crocetin was found as the more potent one. Overall, this research suggests that crocetin is a potential anticancer agent that can be used for cancer prevention and treatment.

Graphic abstract


Antiproliferative Cancer Cell death Crocetin Crocus sativus L. Saffron 



The author would like to thank Gaziantep University, Medical Biology Department, Genetics Research Laboratory for their technical support.

Compliance with ethical standards

Conflict of interest

The author declares that they have no conflict of interest.


  1. Abdullaev FI, Riveron-Negrete L, Caballero-Ortega H, Hernández JM, Perez-Lopez I et al (2003) Use of in vitro assays to assess the potential antigenotoxic and cytotoxic effects of saffron (Crocus sativus L.). Toxicol In Vitro 17(5–6):731–736. CrossRefPubMedGoogle Scholar
  2. Al-Qubaisi M, Rozita R, Yeap SK, Omar AR, Ali AM et al (2011) Selective cytotoxicity of goniothalamin against hepatoblastoma HepG2 cells. Molecules 16(4):2944–2959. CrossRefPubMedPubMedCentralGoogle Scholar
  3. Amin A, Hamza AA, Bajbouj K, Ashraf SS, Daoud S (2011) Saffron: a potential candidate for a novel anticancer drug against hepatocellular carcinoma. Hepatology 54(3):857–867. CrossRefPubMedGoogle Scholar
  4. Ashktorab H, Soleimani A, Singh G, Amr A, Tabtabaei S, Latella G et al (2019) Saffron: the golden spice with therapeutic properties on digestive diseases. Nutrients 11(5):943. CrossRefPubMedCentralGoogle Scholar
  5. Balunas MJ, Kinghorn D (2005) Drug discovery from medicinal plants. Life Sci 78(5):431–441. CrossRefPubMedGoogle Scholar
  6. Bathaie SZ, Hoshyar R, Miri H, Sadeghizadeh M (2013) Anticancer effects of crocetin in both human adenocarcinoma gastric cancer cells and rat model of gastric cancer. Biochem Cell Biol 91(6):397–403. CrossRefPubMedGoogle Scholar
  7. Bathaie SZ, Bolhassani A, Tamanoi F (2014) Anticancer effect and molecular targets of saffron carotenoids. Enzymes 36:57–86. CrossRefPubMedGoogle Scholar
  8. Bolhassani A, Khavari A, Bathaie SZ (2014) Saffron and natural carotenoids: biochemical activities and anti-tumor effects. Biochim Biophys Acta (BBA) Rev Cancer 1845(1):20–30. CrossRefGoogle Scholar
  9. Chakraborty A, Gupta N, Ghosh K, Roy P (2010) In vitro evaluation of the cytotoxic, anti-proliferative and anti-oxidant properties of pterostilbene isolated from Pterocarpus marsupium. Toxicol In Vitro 24(4):1215–1228. CrossRefPubMedGoogle Scholar
  10. Christodoulou E, Kadoglou NP, Kostomitsopoulos N, Valsami G (2015) Saffron: a natural product with potential pharmaceutical applications. J Pharm Pharmacol 67(12):1634–1649. CrossRefPubMedGoogle Scholar
  11. Dhar A, Mehta S, Dhar G, Dhar K, Banerjee S et al (2009) Crocetin inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model. Mol Cancer Ther 8(2):315–323. CrossRefPubMedGoogle Scholar
  12. Festuccia C, Mancini A, Gravina GL, Scarsella L, Llorens S et al (2014) Antitumor effects of saffron-derived carotenoids in prostate cancer cell models. Biomed Res Int. CrossRefPubMedPubMedCentralGoogle Scholar
  13. Gezici S (2018) Promising anticancer activity of lavender (Lavandula angustifolia Mill) essential oil through induction of both apoptosis and necrosis. Ann Phytomed 7(2):38–45. CrossRefGoogle Scholar
  14. Gezici S (2019) Anticancer, antiproliferative, lysosomal and lactate dehydrogenase inhibitory effects of fruit extracts from sumac (Rhus coriaria L.) on human lung cancer cells. Acta Oncol Turc 52(1):160–168. CrossRefGoogle Scholar
  15. Gezici S, Sekeroglu N (2017) Regulation of MicroRNAs by natural products and bioactive compounds obtained from common medicinal plants: novel strategy in cancer therapy. Indian J Pharm Educ Res 51(3):483–488. CrossRefGoogle Scholar
  16. Gezici S, Sekeroglu N (2019a) Current perspectives in the application of medicinal plants against cancer: novel therapeutic agents. Anticancer Agents Med Chem 19(1):101–111. CrossRefPubMedGoogle Scholar
  17. Gezici S, Sekeroglu N (2019b) Neuroprotective potential and phytochemical composition of acorn fruits. Ind Crops Prod 128:13–17. CrossRefGoogle Scholar
  18. Gezici S, Sekeroglu N, Kijjoa A (2017) In vitro anticancer activity and antioxidant properties of essential oils from Populus alba L. and Rosmarinus officinalis L. from South Eastern Anatolia of Turkey. Indian J Pharm Educ Res 51(3):498–503. CrossRefGoogle Scholar
  19. Giaccio M (2004) Crocetin from saffron: an active component of an ancient spice. Crit Rev Food Sci Nutr 44(3):155–172. CrossRefPubMedGoogle Scholar
  20. Gutheil GW, Reed G, Ray A, Anant S, Dhar A (2012) Crocetin: an agent derived from saffron for prevention and therapy for cancer. Curr Pharm Biotechnol 13(1):173–179. CrossRefPubMedPubMedCentralGoogle Scholar
  21. Kim SH, Lee JM, Kim SC, Park CB, Lee PC (2014) Proposed cytotoxic mechanisms of the saffron carotenoids crocin and crocetin on cancer cell lines. Biochem Cell Biol 92(2):105–111. CrossRefPubMedGoogle Scholar
  22. Li CY, Huang WF, Wang QL, Wang F, Cai E et al (2012) Crocetin induces cytotoxicity in colon cancer cells via p53-independent mechanisms. Asian Pac J Cancer Prev 13(8):3757–3761. CrossRefPubMedGoogle Scholar
  23. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1–2):55–63. CrossRefPubMedGoogle Scholar
  24. Newman DJ, Cragg GM (2016) Natural products as sources of new drugs from 1981 to 2014. J Nat Prod 79(3):629–661. CrossRefGoogle Scholar
  25. Pan L, Chai H, Kinghorn AD (2010) The continuing search for antitumor agents from higher plants. Phytochem Lett 3(1):1–8. CrossRefPubMedPubMedCentralGoogle Scholar
  26. Patel S, Sarwat M, Khan TH (2017) Mechanism behind the anti-tumour potential of saffron (Crocus sativus L.): the molecular perspective. Crit Rev Oncol Hematol 115:27–35. CrossRefPubMedGoogle Scholar
  27. Reddy L, Odhav B, Bhoola KD (2003) Natural products for cancer prevention: a global perspective. Pharmacol Ther 99(1):1–13. CrossRefPubMedGoogle Scholar
  28. Roleira FM, Varela CL, Costa SC, Tavares-da-Silva EJ (2018) Phenolic derivatives from medicinal herbs and plant extracts: anticancer effects and synthetic approaches to modulate biological activity. Stud Nat Prod Chem 57:115–156. CrossRefGoogle Scholar
  29. Seca A, Pinto D (2018) Plant secondary metabolites as anticancer agents: successes in clinical trials and therapeutic application. Int J Mol Sci 19(1):263. CrossRefPubMedCentralGoogle Scholar
  30. Senol FS, Sekeroglu N, Gezici S, Kilic E, Orhan IE (2018) Neuroprotective potential of the fruit (acorn) from Quercus coccifera L. Turk J Agric For 42(2):82–87. CrossRefGoogle Scholar
  31. Siegel RL, Miller KD, Jemal A (2018) Cancer statistics. CA Cancer J Clin 68(1):7–30. CrossRefGoogle Scholar
  32. Song M, Vogelstein B, Giovannucci EL, Willett WC, Tomasetti C (2018) Cancer prevention: molecular and epidemiologic consensus. Science 361(6409):1317–1378. CrossRefPubMedPubMedCentralGoogle Scholar
  33. Strober W (2015) Trypan blue exclusion test of cell viability. Curr Protoc Immunol 111(1):A3.B.1–A3.B.3. CrossRefGoogle Scholar
  34. Tan BL, Norhaizan ME (2018) Plant-derived compounds in cancer therapy: traditions of past and drugs of future. In: Akhtar M, Swamy M (eds) Anticancer plants: properties and application. Springer, Singapore, pp 91–127. CrossRefGoogle Scholar
  35. Tavakkol-Afshari J, Brook A, Mousavi SH (2008) Study of cytotoxic and apoptogenic properties of saffron extract in human cancer cell lines. Food Chem Toxicol 46(11):3443–3447. CrossRefPubMedGoogle Scholar

Copyright information

© Association of Food Scientists & Technologists (India) 2019

Authors and Affiliations

  1. 1.Department of Molecular Biology and Genetics, Faculty of Science and LiteratureKilis 7 Aralık UniversityKilisTurkey
  2. 2.Genetics LaboratoryAdvanced Technology Application and Research Center (ATARC)KilisTurkey

Personalised recommendations